FDA Grants Breakthrough Device Designation to Tempus' HLA-LOH Companion Diagnostic Test
Nephron Pharmaceutical names new chief procurement officer
Belluscura secures 6,500 DISCOV-R orders, demonstrates strong market demand
Anteris Technologies' DurAVR THV proves successful in second valve-in-valve procedure
Rokit Healthcare receives certification under CEMDR for 'Dr Invivo AI Regen Platform'
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
Paindrainer AB's innovative pain management app secures FDA Class 1 approval
Anteris Technologies Launches ADR program for US investors
Pharming initiates Phase III trial in Japan for leniolisib in APDS treatment
Pharming enrols first patient in Phase III leniolisib clinical trial in Japan
Complement Therapeutics names new chief medical officer
Belluscura expands respiratory offerings with McKesson distribution agreement